176 patents currently held
63 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.
The next term ends in Mar 2027. from the record
Of the 63 now held by other companies, 9 name Silicon Microgravity Limited as their current owner, and 54 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
22
Ending by 2030
Mar 2027
Next term end
157
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2030 · High confidence
Also notable
Ends Mar 2030 · High confidence
Also notable
Ends Jul 2033 · High confidence
Overnight Closed-Loop Insulin Delivery with Model Predictive Control and Glucose Measurement Error Model
US 8,062,249
Cited by 219 later US patents, top 5% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Nucleic Acid Amplification and Testing
US 10,563,254
Cited by 17 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2030.
Transcription Factor Mediated Programming Towards Megakaryocytes
US 10,604,738
Cited by 15 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2033.
Formerly held, still cited
Notable
Ends Jul 2038 · High confidence
Cited by 13 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2038.
now held by Cambridge Gan Devices Limited
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 19 to 21, 2026 · next Nov 19
- 2 fees due Dec 25 to 30, 2026 · next Dec 25
- 4 fees due Jan 2 to 16, 2027 · next Jan 2
- 4 fees due Feb 4 to 20, 2027 · next Feb 4
- 1 fee due Mar 12, 2027The maintenance fee for Treatment of Polymer Particles (US 11,753,508) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 1 fee due Apr 29, 2027The maintenance fee for Method of Producing Graphene (US 10,458,026) comes due Apr 29, 2027. Unpaid by Oct 29, 2027, it lapses early.
- 2 fees due May 14 to 19, 2027 · next May 14
- 5 fees due Jul 9 to 30, 2027 · next Jul 9
- 5 fees due Aug 6 to 25, 2027 · next Aug 6
- 5 fees due Sep 1 to 30, 2027 · next Sep 1
- 1 fee due Oct 16, 2027The maintenance fee for Fluidic Separation and Detection (US 11,959,923) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
- 3 fees due Nov 5 to 14, 2027 · next Nov 5
Recent changes
- Oct 9Assignment recorded on 1 record: Carrington, Mark and 2 others to Cambridge Enterprise Limited Recorded Oct 9, 2026, executed Jun 14, 2025. Conveyance as recorded: Confirmatory Assignment. A recorded assignment is a filed document, not a statement of current ownership. Reel 76682, frame 56.
- 8 of the patents on this record were granted since Aug 19, 2026
- 5 terms have ended since Aug 19, 2026
What they patent
The 5 largest of its 157 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Nanopore Functionality Control | 3 in force | to Aug 2036 |
| Treatment of Diseases Related to Hyperactivity of the Complement System | 3 in force | to Mar 2030 |
| BENZO[C][2,6]NAPHTHYRIDINE Derivatives, Compositions and Therapeutic Uses Thereof | 2 in force | to Feb 2042 |
| Magnetic Particle and Method | 2 in force | to Oct 2041 |
| Compounds for Use as Apelin Receptor Antagonists | 2 in force | to Apr 2039 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,780,994 | Composite Biomaterials Comprising Calcium Phospate Materials, Collagen and Glycosaminoglycans In force · High confidence | In force | High confidence | |
| US D685,478 | Control Device In force · High confidence | In force | High confidence | |
| US 8,641,946 | Extrudate Having Capillary Channels In force · High confidence | In force | High confidence | |
| US 10,538,742 | Methods And Means Related To Cancer Stem Cells In force · High confidence | In force | High confidence | |
| US 8,323,789 | Nanomaterial Polymer Compositions and Uses Thereof In force · Medium confidence | In force | Medium confidence | |
| US 7,951,270 | Microwave Induced Pyrolysis Reactor and Method In force · High confidence | In force | High confidence | |
| US 8,085,453 | Phase Retrieval and Phase Hologram Synthesis In force · High confidence | In force | High confidence | |
| US 8,159,733 | Method of Forming an Image and Image Projection Device In force · High confidence | In force | High confidence | |
| US 8,378,059 | Supramolecular Handcuffs in Polymeric Architecture In force · High confidence | In force | High confidence | |
| US 8,323,971 | Differentiation of Pluripotent Cells into Primary Germ Layer Progenitors In force · High confidence | In force | High confidence |
Also on record, not counted in the 176: 63 patents in force now held by others · 136 patents ended · 182 applications pending · 213 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.